Market revenue in 2022 | USD 220.6 million |
Market revenue in 2030 | USD 614.1 million |
Growth rate | 13.7% (CAGR from 2022 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Enzymes |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Enzymes |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, Qiagen NV, New England Biolabs, Merck KGaA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Takara Bio Inc, LGC Group, Bausch Health Companies Inc, Promega |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular biology enzymes, reagents and kits market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 67.36% in 2022. Horizon Databook has segmented the Australia molecular biology enzymes, reagents and kits market based on kits & reagents, enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
Australian Society for Biochemistry and Molecular Biology (ASBMB) is focused on increasing interactions between molecular biologists and biochemists around Australia. ASBMS promotes research, development, and education in molecular biology and biochemistry.
In addition, EMBL Australia is a project supported by National Research Infrastructure for Australia (NCRIS) program. This project offers research opportunities in life sciences arena by providing partner laboratory network, nationwide student training programs, and support from EMBL Australia Bioinformatics Resource (EMBL-ABR).
Presence of such organizations and government initiatives is expected to increase the use of molecular biology enzymes, kits, and reagents in the country, further driving the market growth. Moreover, Australian Genomics is a research partnership between more than 80 organizations for the assessment of the application of genomic testing in healthcare.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia molecular biology enzymes, reagents and kits market , including forecasts for subscribers. This country databook contains high-level insights into Australia molecular biology enzymes, reagents and kits market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account